Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer-Reference-Cited by-同舟云学术

Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer

Published:2013-09 Issue:1 Volume:222 Page:23-35
ISSN:0378-4274
Container-title:Toxicology Letters
language:en
Short-container-title:Toxicology Letters

Author:

Bao Guo-Qing,Shen Bai-Yong,Pan Chun-Peng,Zhang Ya-Jing,Shi Min-Min,Peng Cheng-Hong

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference54 articles.

1. Deregulation of PI3K/Akt/mTOR signaling pathways by isoflavones and its implication in cancer treatment;Ahmad;Anticancer Agents in Medical Chemistry,2012

2. STAT3 as a target for inducing apoptosis in solid and hematological tumors;Al Zaid Siddiquee;Cell Research,2008

3. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer;Banerjee;Cancer Research,2009

4. Pancreatic cancer biology and genetics;Bardeesy;Nature Reviews Cancer,2002

5. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;Journal of Clinical Oncology,1997

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Andrographolide suppresses the malignancy of pancreatic cancer via alleviating DNMT3B-dependent repression of tumor suppressor gene ZNF382;Phytomedicine;2024-09

2. Andrographolide enhances the antitumor activity of cisplatin by inhibiting the PI3K/AKT signaling pathway in bladder cancer;2024-08-07

3. Andrographolide induces protective autophagy and targeting DJ-1 triggers reactive oxygen species-induced cell death in pancreatic cancer;PeerJ;2024-06-28

4. Design, synthesis, and anti-cancer evaluation of C-14 arylcarbamate derivatives of andrographolide;Bioorganic & Medicinal Chemistry;2024-01

5. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs;Drug Resistance Updates;2023-11